CSIMarket
 

Neurometrix Inc   (NURO)
Other Ticker:  
 

Neurometrix Inc 's Working Capital Per Sales

NURO's Working Capital and Revenue growth



NURO Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change -14.72 % -9.97 % -8.51 % -9.18 % 0.78 %
Y / Y Revenue Change -80.31 % -38.86 % -22.57 % -25.09 % 1.5 %
Working Capital Per Revenue 4.13 3.31 3.03 2.91 2.77
Total Ranking # 1517 # 2939 # 1560 # 2174 # 2212
Seq. Working Capital Change 0.87 % -7.75 % -2.72 % -5.79 % 6.49 %
Seq. Revenue Change -69.77 % -27.33 % -4 % -6.64 % -6.13 %





Comment on NURO's Working Capital Per Revenue in the fourth quarter 2023
Neurometrix Inc 's Working Capital Per Revenue sequentially grew to 4.13 during the Q4 2023, a new company high. Due to increase of revenue in the Q4 2023 year on year by -80.31%.

Within Healthcare sector 24 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Neurometrix Inc Working Capital Per Revenue overall ranking has impoved so far in the Q4 2023 to 1517, from total ranking in the third quarter 2023 at 2939.
Working Capital Per Revenue Ranking
Within: No.
Industry # 5
Sector # 25
S&P 500 # 1517


Working Capital Per Revenue Statistics
High Average Low
4.13
1.35
0.27
(Dec 31 2023)   (Mar 31 2018)



Financial Statements
Neurometrix Inc 's Working Capital $ 20 Millions Visit NURO's Balance sheet
Neurometrix Inc 's Revenues $ 0 Millions Visit NURO's Income Statement
Where are NURO's Sales coming from? Visit NURO's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
C4 Therapeutics Inc   10.68 
Co diagnostics Inc   10.46 
Dbv Technologies S a   9.52 
Delcath Systems Inc   9.30 
Caribou Biosciences Inc   7.85 
Recursion Pharmaceuticals Inc   7.73 
Ac Immune Sa  7.54 
Prothena Corporation Public Limited Company  6.78 
Lipella Pharmaceuticals Inc   6.67 
Vaxart Inc   6.61 
Foghorn Therapeutics Inc   6.54 
Werewolf Therapeutics Inc   6.41 
Arcus Biosciences Inc   6.35 
Inspiremd Inc   5.95 
Curis Inc   5.87 
Innovative Eyewear Inc   5.32 
Hookipa Pharma inc   5.24 
Mersana Therapeutics Inc   5.11 
Aadi Bioscience Inc   5.03 
Maxcyte inc   4.98 
Profound Medical Corp   4.94 
Soligenix inc   4.73 
Arcutis Biotherapeutics Inc   4.72 
Cara Therapeutics inc   4.69 
Biontech Se  4.57 
Zymeworks Inc   4.42 
Liquidia Corporation  4.41 
Meiragtx Holdings Plc  4.36 
Legend Biotech Corporation  4.24 
Marker Therapeutics inc   4.19 
Date modified: 2024-03-06T17:24:00+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com